{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-002728","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.803827+00:00","generated_at":"2026-05-28T04:51:10.685102+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeuroOne receives Nasdaq delisting determination for bid price non-compliance; intends to appeal","bullets":["Received delisting determination from Nasdaq on Jan 8, 2025 for continued non-compliance with $1.00 minimum bid price rule.","180-day compliance period ended Jan 7, 2025; company failed to regain compliance.","Company will request a hearing before Nasdaq Hearings Panel to appeal; hearing stays delisting action pending outcome.","Common stock (NMTC) remains listed and tradable at least until final hearing conclusion.","No assurance of regaining compliance or continued listing on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-002728","json":"https://secwatch.observer/filing/0001213900-25-002728.json","markdown":"https://secwatch.observer/filing/0001213900-25-002728.md","text":"https://secwatch.observer/filing/0001213900-25-002728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025002728/0001213900-25-002728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025002728/ea0227395-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:51:10.685102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"007f41d35d30ef7979d757eddb160be4abad6499","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"January 8, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common stock would be delisted from The Nasdaq Capital Market unless the Company appeals the Staff’s delisting determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company’s request for a hearing will stay any further delisting action by the Staff pending the ultimate outcome of the hearing. The Company’s common stock will remain listed and eligible","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025002728/0001213900-25-002728-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"0c5c9ed0104d021296d0892ae8deab1b8a1d345d","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"January 8, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common st","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025002728/0001213900-25-002728-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}